Independent provider comparison

Updated September 26, 2026

MEDVi vs Willow: Which GLP-1 provider is better?

A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
36 providers verified independently·Independent researchHow we rank →

The decision

Which should you choose, MEDVi or Willow?

Short answer: Willow scores higher on our published rubric, 7.5/10 against 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Willow is from $299/mo.

Consider MEDVi if

Users who want both oral and injectable compounded options in one telehealth program.

Consider Willow if

Users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide.

Scores follow our published methodology. Partnership status does not change the score or the factual comparison.

Cost

First charge, renewal and commitment

Treatment

Medication, form and approval status

Care

Clinical review and ongoing support

Terms

Cancellation and material cautions

MEDVi logo

MEDVi

#25 of 36
5.7/10

Best for users who want both oral and injectable compounded options in one telehealth program.

Visit MEDVi
Higher Rated
Willow logo

Willow

#10 of 36
7.5/10

Best for users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide.

Visit Willow

Side by side

MEDVi vs Willow at a glance

Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.

FeatureMEDViWillow
Why each oneA daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership.
A compounded program with separate semaglutide and tirzepatide dissolving tablets, plus a combination tablet. The format choice may suit a reader who wants to discuss needle-free treatment with a clinician; it does not establish equivalence to an approved pill or injection.
Our Score5.7/107.5/10
Headline Price$179 first month, then $299/mofrom $299/mo
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForUsers who want both oral and injectable compounded options in one telehealth program
Users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide
Watch out forFDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking#25#10
Get startedVisit MEDViVisit Willow

Trade-offs

Strengths and cautions compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
  • +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
  • +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping

Cons

  • −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
  • −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
  • −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
  • −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
  • −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Willow

Pros

  • +Includes monthly provider check-ins and dose adjustments at no extra cost
  • +Compounded daily dissolving tablets for semaglutide and tirzepatide, offering a needle-free format to discuss with the prescriber
  • +$299/mo covers compounded semaglutide at the starting doses, injectable or tablet, with monthly provider support and no separate consultation fee
1 more documented strengths
  • +A US licensed doctor reviews and confirms the prescription the same day, and two-day shipping is free, both stated on the product pages (verified 2026-09-03)

Cons

  • −Compounded-only, no brand-name Wegovy or Zepbound through the platform
  • −Both headline prices are floors. Tirzepatide starts at $399/mo against $299 for semaglutide, and on the help center pricing article maintenance tirzepatide injections run $499/mo from 8.5 mg, $524/mo at 13.5 mg and $549/mo at 17 mg (checked 2026-09-03)
  • −Cash-pay only. Willow does not bill insurance. You pay with an HSA or FSA card at checkout, or pay out of pocket and submit receipts to your insurer yourself, with reimbursement depending on your plan and deductible (checked 2026-09-03)
1 more documented cautions
  • −The program auto-renews, and a cancellation has to reach the care team at least two business days before the next processing date to stop a charge. A full refund only applies if you cancel before the prescription goes to the pharmacy, and the informed consent page says orders cannot be cancelled, returned or refunded once shipped (checked 2026-09-03)

Our Verdict

Willow edges out MEDVi with a score of 7.5/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Willow is from $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility.

Keep narrowing the decision

What should you compare next?

Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both MEDVi and Willow start above the cheapest complete recurring program we track. Across all 36 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Try Willow

Headline price: from $299/mo

Visit Willow

Reviews and pricing sources

Related comparisons

More head-to-head comparisons involving MEDVi and Willow.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is MEDVi legit and is Willow legit, with the verification evidence behind each answer.